Non-invasive optoacoustic imaging of proteinopathy in mouse models of Alzheimer’s disease
Dr. Ruiqing Ni, group leader at the Institute for Regenerative Medicine, UZH and Institute for Biomedical Engineering, ETH
Medical device company iThera Medical announces successful closure of €13 Million investment round, led by TRUMPF Venture with participation by the EIC Fund as co-investor in addition to existing investors Mey Capital Matrix, Wachstumsfonds Bayern, BayBG, Fluxunit, Falk Strascheg Holding, and Occident. The funding will drive the company’s continued innovation and commercialization of its novel medical imaging technology, with a specific goal to translate the technology into a routine clinical environment and offer clinicians worldwide a powerful new diagnostic tool.
Dr. Ruiqing Ni, group leader at the Institute for Regenerative Medicine, UZH and Institute for Biomedical Engineering, ETH
Emily L. Geisler, medical student at the Wertheim College of Medicine, FL, USA.
If you have any questions about our technology, applications or products, don’t hesitate to get in touch.
Address Zielstattstrasse 13, 81379 Munich, Germany
Email info@ithera-medical.com